Linganisha mbinu
Pitia mbinu ulizochagua bega kwa bega; safu zinazotofautiana zinaangaziwa.
| Uchanganuzi wa Kukuza Kundi la Jeni la Multi-omics× | Uchambuzi wa Utekelezaji Tofauti wa RNA-seq× | |
|---|---|---|
| Nyanja | Bioinformatiki | Bioinformatiki |
| Familia | Process / pipeline | Process / pipeline |
| Mwaka wa asili≠ | 2005 (GSEA foundation); multi-omics extensions ~2013–2020 | 2008–2010 (RNA-seq DE methodology established) |
| Mwanzilishi≠ | Extended from Subramanian et al. (2005); multi-omics integration formalized ~2010s | Multiple groups; foundational methods from Anders & Huber (DESeq, 2010), Robinson, McCarthy & Smyth (edgeR, 2010) |
| Aina≠ | Integrative enrichment analysis pipeline | Quantitative genomics pipeline |
| Chanzo asilia≠ | Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., & Mesirov, J. P. (2005). Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proceedings of the National Academy of Sciences, 102(43), 15545–15550. DOI ↗ | Love, M. I., Huber, W., & Anders, S. (2014). Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biology, 15(12), 550. DOI ↗ |
| Majina mbadala | multi-omics GSEA, integrated GSEA, cross-omics pathway enrichment, multi-layer GSEA | RNA-seq DE analysis, transcriptomic differential expression, bulk RNA-seq DE, DEA |
| Zinazohusiana | 6 | 6 |
| Muhtasari≠ | Multi-omics gene set enrichment analysis (multi-omics GSEA) is a computational pipeline that applies GSEA logic simultaneously across two or more molecular measurement layers — such as transcriptomics, proteomics, and metabolomics — to identify biological pathways or gene sets that are coordinately dysregulated across omics platforms. By integrating ranked molecular signatures from each layer, it reveals pathway-level convergence that no single omics platform could detect alone. | RNA-seq differential expression (DE) analysis identifies genes whose transcript abundance differs significantly between two or more biological conditions — for example, treated versus control, or diseased versus healthy tissue. Starting from raw sequencing reads, the pipeline moves through alignment, count-based normalization, statistical modeling of count dispersion, hypothesis testing, and multiple-testing correction to produce a ranked list of differentially expressed genes accompanied by fold-change estimates and adjusted p-values. |
| ScholarGateSeti ya data ↗ |
|
|